Riskpilot← Back to searchSign inGet full accessSANDVIKA SPESIALISTSENTER AS
ASActiveOrg 8993265123. Etg Elias Smiths Vei 24, 1337 SandvikaMedical specialists activities · NACE 8622Est. 20136 employees
Revenue 2025
NOK 5,5M
-4% vs 2024
EBITDA margin
4.6%
+105% vs 2024
Equity ratio
33.7%
Financial strength
Net profit 2025
NOK 141K
+87% vs 2024
| Revenue | NOK 5,5M | -4% |
| EBITDA | NOK 252K | +105% |
| Net profit | NOK 141K | +87% |
| Total assets | NOK 2,4M | +7% |
| Equity | NOK 812K | +21% |
| Employees | 6 | — |
Legal name
SANDVIKA SPESIALISTSENTER AS
Org number
899326512
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
5. januar 2013
Share capital
NOK 40 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Drift av spesialistlegesenter med hovedvekt på undersøkelse og behandling av gynekologiske, indremedisinske og dermatologiske sykdommer. Samarbeidsavtalen for sandvika spesialistsenter gjelder inntil ny aksjonæravtale foreligger.
Address
3. Etg Elias Smiths Vei 24, 1337 Sandvika
Phone
+4767575859
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 760 | 4 120 | 4 320 | 5 720 | 5 501 |
| Staff expenses | −2 138 | −2 384 | −2 498 | −2 690 | −2 412 |
| EBITDA | 123 | 123 | 124 | 123 | 252 |
| Depreciation & amort. | −7 | −7 | −12 | −51 | −84 |
| EBIT | 116 | 116 | 112 | 72 | 169 |
| Net financials | −0 | 2 | −0 | 26 | 14 |
| Profit before tax | 116 | 118 | 112 | 98 | 183 |
| Tax | 26 | 26 | 25 | 22 | 42 |
| Net profit | 90 | 92 | 87 | 75 | 141 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 820 | 1 050 | 1 110 | 2 260 | 2 410 |
| Equity | 416 | 508 | 595 | 671 | 812 |
| Long-term debt | 2 | 3 | 1 | 1 137 | 1 136 |
| Short-term debt | 402 | 539 | 514 | 452 | 463 |
| Total debt | 404 | 541 | 515 | 1 589 | 1 599 |
EBITDA margin
4.6%
This company
15.8%
Market median
-71% vs market
20212025
Equity ratio
33.7%
This company
38.2%
Market median
+12% vs market
20212025
Return on equity
17.4%
This company
18.4%
Market median
+5% vs market
20212025
Net profit margin
2.6%
This company
8.1%
Market median
-68% vs market
20212025
Asset turnover
2.28×
This company
1.12×
Market median
+104% vs market
20212025
Debt / equity
1.97×
This company
0.62×
Market median
-218% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PJ Chief Executive Officer | Chief Executive Officer | 2013 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2026 | |
| Chairman | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 25% | 25% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Konkoi As
SANDVIKA SPESIALISTSENTER AS Board members of SANDVIKA SPESIALISTSENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pål Johan Vanberg | Chief Executive Officer | 0 companies |
| Runa Sigrid Aabø | Board of Directors | 0 companies |
| Aase Høviskeland | Board of Directors | 0 companies |
| Ersan Krckov | Board of Directors | 0 companies |
| Oskar Johan Skår | Chairman | 0 companies |